SOLICITATION NOTICE
65 -- reagents
- Notice Date
- 1/12/2018
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- 1194439
- Point of Contact
- Julia A Savage, Phone: 2404027616
- E-Mail Address
-
julia.savage@fda.hhs.gov
(julia.savage@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Contracting Office Address Department of Health and human Services, Office of Acquisition and Grants Services (OAGS), 5630 Fishers Lane, Rockville, MD 20857. Description: (i)This is a Combined/Synopsis Solicitation for Commercial Items prepared in accordance with the format in FAR Part 12, as supplemented with additional information included in this notice. The requirement will be awarded using Simplified Acquisition Procedures in accordance with FAR Part 13. (ii)The solicitation number is: FDA-1194439 (iii)The Solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular (FAC) 2005-96, November 6, 2017. (iv)This is a firm fixed price requirement. The associated North American Industrial Classification System (NAICS) code for this procurement is 334516. This procurement will be for a small business set aside. Vendors must be registered in the System for Award Management (SAM) prior to the award of a contract. You may register by going to www.sam.gov (v)The Food and Drug Administration (FDA)is a regulatory agency with responsibility for the safety of food for humans and animals and the safety and efficacy of drug, devices and other medical products. In support of this regulatory mission, the Center for Veterinary Medicine (CVM), runs a laboratory at the Office of Research in Laurel, MD that investigates antimicrobial resistance genes and mobile genetic elements that facilitates emergence and dissemination of multi-drug resistance (MDR) among foodborne pathogens. To advance these directives, the Division of Animal and Food Microbiology (DAFM) recently acquired a PacBio Sequel Sequencer to provide unbiased coverage and long read length (>8KB) for plasmids and bacterial genomes closure. FDA/DAFM needs to acquire specific reagents for this instrument to continue with this research. The FDA intends to award a firm fixed price contract for this award. (vi)Delivery schedule and list of supplies/reagents. The contractor is required to deliver the following products on the specified dates: Product Part Number 4/3/18 5/2/18 6/5/18 7/3/18 8/2/18 Total Qty Barcoded Adapter Plate (96) 100-466-000 1 1 0 1 1 4 Sequel TM SMRT® Cell 1M v2 Tray (4 Cells) 101-008-000 4 5 4 4 4 21 (vii)The period of performance: The planned Period of Performance is from 4/18 thru 9/18 with monthly deliveries April thru August. FOB Point of Delivery for the Supplies provided will be the Food and Drug Administration, ATTN: Cong Li, 8401 Muirkirk Rd, Building MOD 2, Laurel MD, 20708. The provision at FAR 52.212-1 Instructions to Offerors- Commercial Items applies to this solicitation. The following addenda have been attached to this provision: None. (viii)The government is not responsible for locating or securing any information, which is not identified in the submission. To ensure sufficient information is available, vendors must furnish as part of their proposal all descriptive material (such as cuts, illustration, drawings, or other information) necessary for the government to determine whether the product meets their requirements. (ix)Offerors must include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications- Commercial Items with its offer. (x)The clause at 52.212-4, Contract Terms and Conditions- Commercial Items, applies to this acquisition. The following addenda have been attached to the clause: None. (xi)The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes of Executive Orders-Commercial Items, applies to this acquisition. The following additional FAR clauses cited in this clause are applicable: 52.219-6, 52.222-3, 52.222-19, 52.222-21, 52.222-26, 52.222-35, 52.222-37, 52.225-1, 52.225-3, 52.225-13, and 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition. Clauses and provisions can be obtained at http://www.acquisition.gov. (xii)A standard commercial warranty is not required. (xiii)The Defense Priorities and Allocations System and assigned rating are not applicable to this solicitation notice. (xiv)This announcement constitutes the only solicitation that will be issued. Offers are due in person, by mail, preferably by e-mail on or before February 1 by 3:00 pm (Eastern Time), at Food and Drug Administration OC/OAGS/DSAAG, Attn: Julia Savage, 5630 Fishers Lane, Rockville MD, 20877. Ph. 240.402.7616, email: Julia.Savage@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1194439/listing.html)
- Place of Performance
- Address: Laurel MD, United States
- Record
- SN04789664-W 20180114/180112231349-b9a6071bbe763477a0a37a10d550a1c9 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |